PROQR THERAPEUTICS NV (PRQR)
NL0010872495 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -27.73M | -64.89M | -61.68M | -46.61M | -56.75M | |||
| Depreciation Amortization | 2.51M | 2.52M | 2.33M | 2.36M | 2.05M | |||
| Change In Working Capital | 50.84M | -9.18M | 22.63M | -6.12M | 2.40M | |||
| Interest Paid | 789.00K | 3.76M | 2.25M | 1.11M | 70.00K | |||
| Taxes Paid | -78.00K | 100.00K | 120.00K | 190.00K | 60.00K | |||
| Other non cash items | -4.07M | 3.04M | 10.71M | 3.32M | 8.32M | |||
| OPERATING CASH FLOW | 21.55M | -68.51M | -26.01M | -47.06M | -43.97M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.37M | -710.00K | -480.00K | -920.00K | -580.00K | |||
| Other Investing Activity | 5.65M | 10.00K | 60.00K | N/A | N/A | |||
| INVESTING CASH FLOW | 4.28M | -700.00K | -430.00K | -920.00K | -580.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -2.63M | -45.05M | 26.84M | 13.77M | 1.46M | |||
| Stock Issued/Repurchased | 354.00K | 14.16M | 110.00M | 740.00K | 48.74M | |||
| FINANCING CASH FLOW | -2.27M | -30.89M | 136.83M | 14.50M | 50.20M | |||
| Exchange Rate Effect | 599.00K | 7.35M | 1.29M | -2.63M | 720.00K | |||
| CHANGE IN CASH | 24.15M | -92.75M | 111.68M | -36.11M | 6.37M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 21.55M | -68.51M | -26.01M | -47.06M | -43.97M | |||
| Capital Expenditure | -1.37M | -710.00K | -480.00K | -920.00K | -580.00K | |||
| FREE CASH FLOW | 20.18M | -69.22M | -26.49M | -47.98M | -44.55M | |||
All data in EUR